Azaindole compounds as kinase inhibitors

Details for Australian Patent Application No. 2004236146 (hide)

Owner AstraZeneca AB

Inventors David, Laurent; Hansen, Peter

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004236146

PCT Pub. Number WO2004/099205

Priority 0301372-9 09.05.03 SE

Filing date 6 May 2004

Wipo publication date 18 November 2004

Acceptance publication date 13 December 2007

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

24 November 2005 PCT application entered the National Phase

  PCT publication WO2004/099205 Priority application(s): WO2004/099205

13 December 2007 Application Accepted

  Published as AU-B-2004236146

10 April 2008 Standard Patent Sealed

2 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004236147-Chemical compounds

2004236144-Imidazo and thiazolopyridines as JAK3 kinase inhibitors